Dr. Nasreen A. Vohra, MD

Dr. Vohra practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Vohra's NPI, 1134308158, was assigned on October 26, 2007. Dr. Vohra graduated from Baylor College of Medicine in 2003. Dr. Vohra holds North Carolina license 2012-01643.

Dr. Vohra's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Dr. Vohra's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dr. Vohra is also affiliated with Outer Banks Health Hospital. The medical group on file is ECU Health. Dmand AI also links Dr. Vohra to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vohra practices, 7 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Vohra's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Vohra's licenses on file in 2 states: North Carolina and Florida.

CMS data shows 240 Medicare services from Dr. Vohra across 9 procedure codes in 2024, for 153 Medicare patients. Medicare paid $17,824 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Vohra in 2024. The largest group is 75 to 84, with 62 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vohra's median patient age at 73, with 44% women.

In 2024, Dr. Vohra wrote 38 Medicare Part D claims for 23 patients. 89% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $112 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Vohra for performance year 2024, reported through an alternative payment model (APM). Dr. Vohra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vohra as offering telehealth. CMS counts 24 procedures of melanoma (skin cancer) excision by Dr. Vohra, more than 77% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 49 papers to Dr. Vohra, published from 2011 to 2023. 2019 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, SEER Program and Pancreatic Neoplasms. Dr. Vohra has published most often in Am Surg. Dr. Vohra's most frequent co-authors are Timothy Louis Fitzgerald, MD, Jan Howe Wong, MD and Emmanuel E. Zervos, MD.

Dmand AI links Dr. Vohra to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 2. Open Payments lists research payments to Dr. Vohra that name 2 trials.

CMS Open Payments shows 15 general payments to Dr. Vohra from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 84% of the total. Histosonics, Inc. paid the most, $1,244. It also lists 3 research payments totaling $9,518 from 2020 to 2024, naming 2 clinical trials.

Dr. Vohra graduated from Baylor College of Medicine in 2003.